We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+8.79%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$17.7B
AUM Growth
+$2.98B
(+20%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
10.19%
Top 10 Holdings %
Top 10 Hldgs %
35.18%
Holding
1,173
New
33
Increased
727
Reduced
328
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$505M |
| 2 |
Intel
INTC
|
+$122M |
| 3 |
Apple
AAPL
|
+$122M |
| 4 |
Microsoft
MSFT
|
+$98.1M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$90.1M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$37.3M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$32.8M |
| 4 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$15.9M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$15.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.79% |
| 2 | Financials | 10.21% |
| 3 | Healthcare | 7.68% |
| 4 | Consumer Discretionary | 4.29% |
| 5 | Energy | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RNAM
351
DELISTED
Avidity Biosciences
RNAM
| $6.74M | 0.04% |
607,510
+226,589
| +59% | +$2.84M |
|
|
352
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.07B
| $6.68M | 0.04% |
72,627
-173,275
| -70% | -$15.9M |
|
|
353
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $6.68M | 0.04% |
88,985
-212,300
| -70% | -$15.8M |
|
354
Texas Pacific Land
TPL
$27.8B
| $6.62M | 0.04% |
45,252
-774
| -2% | -$124K |
|
|
DEN
355
DELISTED
Denbury Inc.
DEN
| $6.6M | 0.04% |
76,549
-24,130
| -24% | -$2.19M |
|
|
SAGE
356
DELISTED
Sage Therapeutics
SAGE
| $6.52M | 0.04% |
138,647
-27,084
| -16% | -$1.35M |
|
357
Northern Oil and Gas
NOG
$2.3B
| $6.42M | 0.04% |
187,186
-63,688
| -25% | -$2.06M |
|
|
IMGN
358
DELISTED
Immunogen Inc
IMGN
| $6.36M | 0.04% |
337,286
-1,030,684
| -75% | -$12.2M |
|
359
Raymond James Financial
RJF
$33.8B
| $6.36M | 0.04% |
61,266
-4,058
| -6% | -$377K |
|
360
Bank of Hawaii
BOH
$3.15B
| $6.35M | 0.04% |
154,110
+131,426
| +579% | +$5.81M |
|
361
Duke Energy
DUK
$97.8B
| $6.32M | 0.04% |
70,480
+13,945
| +25% | +$1.32M |
|
|
SWTX
362
DELISTED
SpringWorks Therapeutics
SWTX
| $6.31M | 0.04% |
240,811
+21,982
| +10% | +$578K |
|
363
Hewlett Packard
HPE
$63.4B
| $6.29M | 0.04% |
374,583
+97,369
| +35% | +$1.49M |
|
364
Krystal Biotech
KRYS
$10.1B
| $6.24M | 0.04% |
53,183
-8,341
| -14% | -$852K |
|
365
Howmet Aerospace
HWM
$113B
| $6.23M | 0.04% |
125,653
-22,811
| -15% | -$1.02M |
|
366
Veracyte
VCYT
$3.7B
| $6.2M | 0.04% |
243,402
-47,344
| -16% | -$1.15M |
|
367
Pinduoduo
PDD
$126B
| $6.18M | 0.03% |
89,386
+32,717
| +58% | +$2.25M |
|
368
Fair Isaac
FICO
$24.3B
| $6.17M | 0.03% |
7,626
+2,144
| +39% | +$1.61M |
|
369
JD.com
JD
$44.6B
| $6.11M | 0.03% |
179,154
+44,976
| +34% | +$1.64M |
|
370
Arcus Biosciences
RCUS
$3.55B
| $6.1M | 0.03% |
300,112
-110,880
| -27% | -$2.11M |
|
371
Old National Bancorp
ONB
$10.2B
| $6.08M | 0.03% |
436,360
+216,555
| +99% | +$2.88M |
|
372
HCA Healthcare
HCA
$87.2B
| $6.07M | 0.03% |
19,987
+1,014
| +5% | +$282K |
|
|
BLUE
373
DELISTED
bluebird bio
BLUE
| $6.05M | 0.03% |
91,873
+6,451
| +8% | +$472K |
|
374
Air Products & Chemicals
APD
$65.7B
| $5.97M | 0.03% |
19,935
+1,185
| +6% | +$337K |
|
375
Associated Banc-Corp
ASB
$5.83B
| $5.96M | 0.03% |
367,468
+194,480
| +112% | +$3.21M |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Rafferty Asset Management held 1,173 positions worth $17.7B, up 20% from $14.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Rafferty Asset Management deployed $1.81B of net new capital in Q2 2023, opening 33 new positions and adding to 727 existing holdings. Its largest new stake was Biomea Fusion: 136,903 shares worth $3.01M.
By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 42% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $90.1M trimmed.
- Rafferty Asset Management's largest Q2 2023 buy was Biomea Fusion: 136,903 shares worth $3.01M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q2 2023, an estimated $505M increase.
- Rafferty Asset Management's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $90.1M.
- Rafferty Asset Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $6.38M.
- Rafferty Asset Management's ten largest holdings make up 35% of its $17.7B portfolio in Q2 2023.
- Rafferty Asset Management opened 33 new positions and closed 84 in Q2 2023.
- Rafferty Asset Management's portfolio value rose 20% quarter-over-quarter to $17.7B.
Based on Rafferty Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.